A stem cell journey in ophthalmology: From the bench to the clinic
- PMID: 34515419
- PMCID: PMC8641078
- DOI: 10.1002/sctm.21-0239
A stem cell journey in ophthalmology: From the bench to the clinic
Abstract
Debilitating diseases of the eye represent a large unmet medical need potentially addressable with stem cell-based approaches. Over the past decade, the California Institute for Regenerative Medicine (CIRM) has funded and supported the translation, from early research concepts to human trials, of therapeutic stem cell approaches for dry age-related macular degeneration, retinitis pigmentosa, and limbal stem cell deficiency. This article chronicles CIRM's journey in the ophthalmology field and discusses some key challenges and questions that were addressed along the way as well as questions that remain.
Keywords: cellular therapy; clinical translation; retina; retinal pigmented epithelium; stem cells.
© 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Conflict of interest statement
The authors declared no potential conflicts of interest.
References
-
- Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. 2009;27(10):2427‐2434. - PubMed
-
- Ao J, Wood JP, Chidlow G, et al. Retinal pigment epithelium in the pathogenesis of age‐related macular degeneration and photobiomodulation as a potential therapy? Clin Exp Ophthalmol. 2018;46(6):670‐686. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous